|
|
|
|
Characterization of LRAP Hydrolytic Peptides and Their Biological Activities
T.Q. LE1, P.P.K. DENBESTEN1, J.D.B. FEATHERSTONE2, and W. LI1, 1University of California, San Francisco, USA, 2University of California San Francisco, USA | Leucine-rich amelogenin peptide (LRAP) is one of the most
abundant alternatively spliced amelogenins. Similar N- and C-terminal sequences between LRAP and
full-length amelogenin suggest that LRAP can be hydrolyzed by MMP-20. Objective: To
characterize LRAP hydrolytic peptides and their biological activities. Methods: Human
recombinant LRAP (200 µL of 29.2 µM) was incubated with active MMP-20 (3µL of
8.6 µM) in Tris/HCl (20 mM), pH 7.5 at 37 °C. At specific times over 3 hrs, aliquots
of enzymatic reaction mixtures were collected for SDS-PAGE and mass
spectrometric analysis. Absorbance
assay and dynamic light scattering (DLS) were used to analyze the aggregation
of LRAP hydrolytic products.
Recombinant N-terminal LRAP and synthetic C-terminal peptide
(STDKTKREEVD) of LRAP, representing two initial hydrolytic peptides, were
synthesized. Functional assays
were used to study the domains of LRAP that bind carbonate hydroxyapatites, and
those that promote dental pulp cell proliferation in vitro. Results: MMP-20 sequentially hydrolyzed LRAP at
3 different cleavage sites, initially at AWP/STD, followed by DLT/LEA, and
finally PLP/PML. After digestion
at 25 °C
and 37 °C,
LRAP hydrolytic products assembled into peptide aggregates, ranging from 222 ± 19
to 325 ±
47 nm, respectively. Binding
experiments showed that LRAP interacted with carbonate hydroxyapatites by the
C-terminal domain. However, the
N-terminal LRAP, lacking the C-terminus, promoted dental pulp cell
proliferation in vitro. Conclusions: LRAP was hydrolyzed by MMP-20 at 3
cleavage sites. The C-terminus of
LRAP bind directly to apatites, modulating crystal growth, while the N-terminal
LRAP hydrolytic product plays a role in cell signaling to regulate tooth
formation. Supported:
NIH/NIDCR T32-DE07306-09 (to T.L.), P01-DE009859 (to P.D.B.) and
R01-DE015821 (to W.L.).
| Seq #88 - Amelogenin & Amelogenin Cleavage Products 2:00 PM-3:15 PM, Thursday, July 3, 2008 Metro Toronto Convention Centre Exhibit Hall D-E |
Back to the Mineralized Tissue Program
|
|